Smoking cessation intervention delivered by social service organisations for a diverse population of Australian disadvantaged smokers: A pragmatic randomised controlled trial

Preventive Medicine

Volumn 112, Issue , 2018, Pages 38-44

  Bonevski, Billie ^a   Twyman, Laura ^b   Paul, Christine ^a   D'Este, Catherine ^a,c   West, Robert ^d   Siahpush, Mohammad ^e   Oldmeadow, Christopher ^f   Palazzi, Kerrin ^f  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b CANCER RESEARCH DIVISION   (Australia)

^c The Australian National University   (Australia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Disadvantaged population; Smoking cessation; Vulnerable groups

Indexed keywords

ABSTINENCE; ADULT; ARTICLE; AUSTRALIA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COUNSELING; FEMALE; HUMAN; INTERVENTION STUDY; LOWEST INCOME GROUP; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SMOKING CESSATION; SOCIAL WORK; NEW SOUTH WALES; ORGANIZATION AND MANAGEMENT; POVERTY; PROCEDURES; SMOKING; STATISTICS AND NUMERICAL DATA; VULNERABLE POPULATION;

ADULT; COUNSELING; FEMALE; HUMANS; MALE; NEW SOUTH WALES; POVERTY; SMOKERS; SMOKING CESSATION; SOCIAL WORK; VULNERABLE POPULATIONS;

EID: 85045015879     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2018.04.005     Document Type: Article

References (30)

1. Barnes, S.A., Larsen, M.D., Schroeder, D., Hanson, A., Decker, P.A., Missing data assumptions and methods in a smoking cessation study. Addiction 105:3 (2010), 431–437.
2. Benowitz, N.L., Jacob, P. III, Ahijevych, K. et al., Biochemical verification of tobacco use and cessation. Nicotine Tob. Res., 4(2), 2002.
3. Bonevski, B., Paul, C., D'Este, C. et al., RCT of a client-centred, caseworker-delivered smoking cessation intervention for a socially disadvantaged population. BMC Public Health, 11(1), 2011, 70.
4. Bonevski, B., O'Brien, J., Frost, S. et al., Novel setting for addressing tobacco-related disparities: a survey of community welfare organization smoking policies, practices and attitudes. Health Educ. Res. 28:1 (2012), 46–57.
5. Bonevski, B., Randell, M., Paul, C. et al., Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med. Res. Methodol., 14(1), 2014, 42.
6. Bryant, J., Bonevski, B., Paul, C., McElduff, P., Attia, J., A systematic review and meta-analysis of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups. Addiction 106:9 (2011), 1568–1585.
7. Bryant, J., Bonevski, B., Paul, C., Hull, P., O'Brien, J., Implementing a smoking cessation program in social and community service organisations: a feasibility and acceptability trial. Drug Alcohol Rev. 31:5 (2012), 678–684.
8. Cahill, K., Stead, L.F., Lancaster, T., Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst. Rev., 12, 2010.
9. Carpenter, J.R., Kenward, M.G., Multiple imputation of unordered categorical data. Multiple Imputation and its Application, 2013, 112–126.
10. Christiansen, B.A., Brooks, M., Keller, P.A., Theobald, W.E., Fiore, M.C., Closing tobacco-related disparities: using community organizations to increase consumer demand. Am. J. Prev. Med. 38:3 (2010), S397–S402.
11. Creoso Corporation, Digivey Survey Suite 3.1.36.0 [Computer Program]. Arizona, USA, 2016.
12. Gartner, C., The potential impact of vaporized nicotine products on vulnerable subpopulations. Addiction 112:1 (2017), 18–19.
13. Hajek, P., West, R., Commentary on Smolkowski et al. (2010): why is it important to assume that non-responders in tobacco cessation trials have relapsed?. Addiction 105:6 (2010), 1016–1017.
14. Hiscock, R., Bauld, L., Amos, A., Fidler, J.A., Munafò M., Socioeconomic status and smoking: a review. Ann. N. Y. Acad. Sci. 1248:1 (2012), 107–123.
15. Hiscock, R., Dobbie, F., Bauld, L., Smoking cessation and socioeconomic status: an update of existing evidence from a national evaluation of English stop smoking services. Biomed. Res. Int., 2015, 2015, 274056, 10.1155/2015/274056.
16. Hughes, J.R., Keely, J.P., Niaura, R.S. et al., Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob. Res. 5:1 (2003), 13–25.
17. Kotz, D., West, R., Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob. Control. 18:1 (2009), 43–46.
18. Kropp, F., Lewis, D., Winhusen, T., The effectiveness of ultra-low magnitude reinforcers: findings from a “real-world” application of contingency management. J. Subst. Abus. Treat. 72 (2017), 111–116.
19. Lawrence, D., Hancock, K.J., Kisely, S., The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ, 346, 2013, f2539.
20. Little, R.J., Selection and pattern mixture models. Fitzmaurice, G., Davidian, M., Verbeke, G., Molenberghs, G., (eds.) Longitudinal Data Analysis, 2008, CRC Press, In.
21. May, S., West, R., Hajek, P., McEwen, A., McRobbie, H., Social support and success at stopping smoking. J. Smok. Cessat. 2:2 (2007), 47–53.
22. Michie, S., Richardson, M., Johnston, M. et al., The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann. Behav. Med. 46:1 (2013), 81–95.
23. Mikhailovich, K., Morrison, P., An evaluation of a smoking cessation program for special populations in Australia. J. Smok. Cessat. 3:1 (2008), 50–56.
24. Roberts, E., Eden Evins, A., McNeill, A., Robson, D., Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis. Addiction 111:4 (2016), 599–612.
25. Song, F., Maskrey, V., Blyth, A. et al., Differences in longer-term smoking abstinence after treatment by specialist or nonspecialist advisors: secondary analysis of data from a relapse prevention trial. Nicotine Tob. Res. 18:5 (2015), 1061–1066.
26. Stead, L.F., Koilpillai, P., Fanshawe, T.R., Lancaster, T., Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Libr, 3, 2016, CD008286.
27. Sterne, J.A., White, I.R., Carlin, J.B. et al., Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ, 338, 2009, b2393.
28. West, R., Hardy, A., A Theory of Addiction. Malden, MA. 2006, Blackwell Publishing, In.
29. West, R., Hajek, P., Stead, L., Stapleton, J., Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 100:3 (2005), 299–303.
30. Wilson, A., Guillaumier, A., George, J., Denham, A., Bonevski, B., A systematic narrative review of the effectiveness of behavioural smoking cessation interventions in selected disadvantaged groups (2010–2017). Expert Rev. Respir. Med. 11:8 (2017), 617–630.